在子宫内膜异位症患者中睡眠障碍的患病率:系统性审查和元分析
Yujie Zhang1, Hui Liu2, Chaochen Feng2
1School of Humanities and Management, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Frontiers in psychiatry
|October 25, 2024
概括
睡眠障碍影响超过70%的子宫内膜异位症患者,在中国的患病率更高,最近增加. 早期干预对于在子宫内膜异位症护理中管理这种常见的并发症至关重要.
科学领域:
- 生殖医学和外科手术
- 睡眠医学 睡眠医学
- 流行病学 流行病学
背景情况:
- 子宫内膜异位症是一种慢性妇科疾病,影响生育年龄的女性.
- 慢性疼痛病患者经常报告睡眠障碍,包括子宫内膜异位症.
- 了解子宫内膜异位症中睡眠问题的患病率对于全面的患者管理至关重要.
研究的目的:
- 系统地分析被诊断为子宫内膜异位症的患者睡眠障碍的全球患病率.
- 确定子宫内膜异位症患者睡眠障碍发生的潜在地理和时间趋势.
- 根据研究设计,评估流行率的差异.
主要方法:
- 在主要数据库 (PubMed, Web of Science, Embase, Wanfang, CNKI) 进行了系统的文献搜索,直到2024年1月.
- 使用的关键词包括"子宫内膜异位症"和"睡眠障碍".
- 从16项涉及2573名参与者的研究中提取和分析了使用Stata 17.0软件的数据.
主要成果:
- 在子宫内膜异位症患者中,睡眠障碍的总体患病率为70.8%.
- 与伊朗 (57.6%) 和欧洲国家 (64.4%) 相比,中国 (78.2%) 的患病率明显高.
- 自2018年以来,人们观察到患病率的显著增加,在队列研究中 (84.0%) 比其他设计中更高.
结论:
- 在患有子宫内膜异位症的妇女中,睡眠障碍非常普遍,这表明有显著的未满足的临床需求.
- 患病率不断上升,特别是在中国,需要集中注意力和研究.
- 建议实施有针对性的干预措施,以预防或缓解睡眠障碍,以改善子宫内膜异位症患者的护理.
相关概念视频
01:24Disorders of the Female Reproductive System
332
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
332
02:07Oogenesis
63.5K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.5K
01:27Insomnia
79
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
79
01:13Insufficient Sleep and Sleep Deprivation
134
Insufficient sleep refers to not getting the recommended amount of sleep for optimal functioning, even if it's just slightly less than needed. Sleep insufficiency may occur due to lifestyle choices, such as staying up late for social events or work, resulting in routinely getting less sleep than required. For example, consistently sleeping 6 hours when the body needs 7-9 hours can lead to cumulative effects on health and well-being.
Sleep deprivation is a more severe form of sleep loss...
Sleep deprivation is a more severe form of sleep loss...
134
01:28Menopause
143
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
143
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
149
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
149